Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
J Neurooncol ; 141(3): 595-607, 2019 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-30659522

RESUMEN

INTRODUCTION: Photodynamic therapy (PDT) is a two-step treatment involving the administration of a photosensitive agent followed by its activation at a specific light wavelength for targeting of tumor cells. MATERIALS/METHODS: A comprehensive review of the literature was performed to analyze the indications for PDT, mechanisms of action, use of different photosensitizers, the immunomodulatory effects of PDT, and both preclinical and clinical studies for use in high-grade gliomas (HGGs). RESULTS: PDT has been approved by the United States Food and Drug Administration (FDA) for the treatment of premalignant and malignant diseases, such as actinic keratoses, Barrett's esophagus, esophageal cancers, and endobronchial non-small cell lung cancers, as well as for the treatment of choroidal neovascularization. In neuro-oncology, clinical trials are currently underway to demonstrate PDT efficacy against a number of malignancies that include HGGs and other brain tumors. Both photosensitizers and photosensitizing precursors have been used for PDT. 5-aminolevulinic acid (5-ALA), an intermediate in the heme synthesis pathway, is a photosensitizing precursor with FDA approval for PDT of actinic keratosis and as an intraoperative imaging agent for fluorescence-guided visualization of malignant tissue during glioma surgery. New trials are underway to utilize 5-ALA as a therapeutic agent for PDT of the intraoperative resection cavity and interstitial PDT for inoperable HGGs. CONCLUSION: PDT remains a promising therapeutic approach that requires further study in HGGs. Use of 5-ALA PDT permits selective tumor targeting due to the intracellular metabolism of 5-ALA. The immunomodulatory effects of PDT further strengthen its use for treatment of HGGs and requires a better understanding. The combination of PDT with adjuvant therapies for HGGs will need to be studied in randomized, controlled studies.


Asunto(s)
Ácido Aminolevulínico/uso terapéutico , Neoplasias Encefálicas/tratamiento farmacológico , Glioma/tratamiento farmacológico , Fotoquimioterapia , Fármacos Fotosensibilizantes/uso terapéutico , Animales , Neoplasias Encefálicas/complicaciones , Ensayos Clínicos como Asunto , Glioma/complicaciones , Humanos , Resultado del Tratamiento
2.
Phys Rev Lett ; 85(6): 1314-7, 2000 Aug 07.
Artículo en Inglés | MEDLINE | ID: mdl-10991540

RESUMEN

We have carried out an experimental and theoretical study of the magnetoresistance MR(H) in the CPP (current perpendicular to the planes) mode for two types of magnetic multilayers that differ only in the ordering of the magnetic layers: [Co(10 A)/Cu(200 A)/Co(60 A)/Cu(200 A)](N) and [Co(10 A)/Cu(200 A)](N)[Co(60 A)/Cu(200 A)](N). The series resistor model predicts that in the CPP mode MR(H) is independent of the ordering of the layers. Nevertheless, the measured MR(H) curves were found to be completely different for the two cases. Calculations based on a realistic band structure and the Kubo formula show that the results are a consequence of a long mean free path.

SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA